DOI: https://doi.org/10.22263/2312-4156.2022.1.20
Palhuyeva H.Y., Makarenko E.V., Lahutchau V.V.
Cryoglobulinemic vasculitis: literature review and clinical case
Vitebsk State Order of Peoples’ Friendship Medical University, Vitebsk, Republic of Belarus
Vestnik VGMU. 2022;21(1):20-30.
Abstract.
The purpose of this work was to analyze literature sources on the diagnosis and treatment of cryoglobulinemic vasculitis with the demonstration of our own data. Cryoglobulinemic vasculitis (CV) is a difficult and rare diagnosis not only for a physician, but also for a rheumatologist. The disease has polymorphic clinical manifestations and can debut with lesions of various organs and systems. Additional difficulties in the diagnosis of the disease are created by ambiguous laboratory research results. CV is often associated with lymphoproliferative diseases such as diffuse large B-cell lymphoma or non-Hodgkin’s lymphoma, autoimmune and infectious diseases. Viral hepatitis C is the most common underlying cause of CV and makes up approximately 80% of all cases. In case when the etiological factor is not established, the term «idiopathic» or «essential» CV is used.
For the diagnosis of CV, classification criteria are proposed, including the results of the questionnaire, clinical manifestations and laboratory research data. The principles of treating patients with CV are determined by the etiopathogenetic mechanisms and the severity of the clinical manifestations of the disease. When the etiological factor of CV development is established, etiotropic therapy is administered. Patients with severe or life-threatening manifestations require urgent intervention to suppress the formation of immune complexes. This is achieved by means of immunosuppressive therapy including glucocorticosteroids, cytostatics, rituximab, and plasmapheresis.
Key words: cryoglobulinemic vasculitis, diagnosis, classification criteria, treatment, cryoglobulinemia, rheumatoid factor.
References
1. Jennette JC, Falk RJ, Bacon P, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. Arthritis Rheum. 2013 Jan;65(1):1-11. doi: http://dx.doi.org/10.1002/art.37715
2. Perez-Alamino R, Espinoza LR. Non-infectious cryoglobulinemia vasculitis (CryoVas): update on clinical and therapeutic approach. Curr Rheumatol Rep. 2014 May;16(5):420. doi: http://dx.doi.org/10.1007/s11926-014-0420-0
3. Lerner AB, Watson CJ. Studies of cryoglobulins I: unusual purpura associated with the presence of a high concentration of cryoglobulin (cold precipitable serum globulin). Am J Med Sci. 1947 Oct;214(4):410-5. doi: http://dx.doi.org/10.1097/00000441-194710000-00009
4. Davuluri S, Bansal P. Cryoglobulinemic Vasculitis. StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. Avaiable from: https://www.ncbi.nlm.nih.gov/books/NBK556045/?report=printable. [Accessed 8th Feb 2022].
5. Cacoub P, Comarmond C, Domont F, Savey L, Saadoun D. Cryoglobulinemia Vasculitis. Am J Med. 2015 Sep;128(9):950-5. doi: http://dx.doi.org/10.1016/j.amjmed.2015.02.017
6. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med. 1974 Nov;57(5):775-88. doi: http://dx.doi.org/10.1016/0002-9343(74)90852-3
7. Trejo O, Ramos-Casals M, García-Carrasco M, Yagüe J, Jiménez S, de la Red G, et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore). 2001 Jul;80(4):252-62. doi: http://dx.doi.org/10.1097/00005792-200107000-00004
8. Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet. 2012 Jan;379(9813):348-60. doi: http://dx.doi.org/10.1016/S0140-6736(11)60242-0
9. Basile U, Napodano C, Marino M, Gulli F, Colantuono S, Casato M, et al. Cryoglobulins: putative effectors of adaptive immune response. Clin Exp Rheumatol. 2021 Mar-Apr;39 Suppl 129(2):171-179.
10. Roncati L, Ligabue G, Fabbiani L, Malagoli C, Gallo G, Lusenti B, et al. Type 3 hypersensitivity in COVID-19 vasculitis. Clin Immunol. 2020 Aug;217:108487. doi: http://dx.doi.org/10.1016/j.clim.2020.108487
11. Matignon M, Cacoub P, Colombat M, Saadoun D, Brocheriou I, Mougenot B, et al. Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infection. Medicine (Baltimore). 2009 Nov;88(6):341-348. doi: http://dx.doi.org/10.1097/MD.0b013e3181c1750f
12. Ghetie D, Mehraban N, Sibley CH. Cold hard facts of cryoglobulinemia: updates on clinical features and treatment advances. Rheum Dis Clin North Am. 2015;41(1):93-108. doi: http://dx.doi.org/10.1016/j.rdc.2014.09.008
13. Romitelli F, Pucillo LP, Basile U, Di Stasio E. Comparison between the traditional and a rapid screening test for cryoimmunoglobulins detection. Biomed Res Int. 2015;2015:783063. doi: http://dx.doi.org/10.1155/2015/783063
14. Vermeersch P, Gijbels K, Mariën G, Lunn R, Egner W, White P, et al. A critical appraisal of current practice in the detection, analysis, and reporting of cryoglobulins. Clin Chem. 2008 Jan;54(1):39-43. doi: http://dx.doi.org/10.1373/clinchem.2007.090134
15. Sargur R, White P, Egner W. Cryoglobulin evaluation: best practice? Ann Clin Biochem.2010 Jan;47(Pt 1):8-16. doi: http://dx.doi.org/10.1258/acb.2009.009180
16. De Vita S, Soldano F, Isola M, Monti G, Gabrielli A, Tzioufas A, et al. Preliminary classification criteria for the cryoglobulinaemic vasculitis. Ann Rheum Dis. 2011 Jul;70(7):1183-90. doi: http://dx.doi.org/10.1136/ard.2011.150755
17. Quartuccio L, Isola M, Corazza L, Ramos-Casals M, Retamozo S, Ragab GM, et al. Validation of the classification criteria for cryoglobulinaemic vasculitis. Rheumatology (xford). 2014 Dec;53(12):2209-13. doi: http://dx.doi.org/10.1093/rheumatology/keu271
18. Terrier B, Krastinova E, Marie I, Launay D, Lacraz A, Belenotti P, et al. Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey. Blood. 2012 Jun;119(25):5996-6004. doi: http://dx.doi.org/10.1182/blood-2011-12-396028
19. Marson P, Monti G, Montani F, Riva A, Mascia MT, Castelnovo L, et al. Apheresis treatment of cryoglobulinemic vasculitis: A multicentre cohort study of 159 patients. Transfus Apher Sci. 2018 Oct;57(5):639-645. doi: http://dx.doi.org/10.1016/j.transci.2018.06.005
20. Ghany MG, Morgan TR. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2020 Feb;71(2):686-721. doi: http://dx.doi.org/10.1002/hep.31060
Information about authors:
Palhuyeva H.Y. – Candidate of Medical Sciences, associate professor of the Chair of Internal Diseases & Ultrasound Diagnostics of the Faculty for Advanced Training & Retraining, Vitebsk State Order of Peoples’ Friendship Medical University;
Makarenko E.V. – Doctor of Medical Sciences, professor of the Chair of Internal Diseases & Ultrasound Diagnostics of the Faculty for Advanced Training & Retraining, Vitebsk State Order of Peoples’ Friendship Medical University;
Lahutchau V.V. – Candidate of Medical Sciences, associate professor of the Chair of Internal Diseases & Ultrasound Diagnostics of the Faculty for Advanced Training & Retraining, Vitebsk State Order of Peoples’ Friendship Medical University.
Correspondence address: Republic of Belarus, 210009, Vitebsk, 27 Frunze ave., Vitebsk State Order of Peoples’ Friendship Medical University, Chair of Internal Diseases & Ultrasound Diagnostics of the Faculty for Advanced Training & Retraining. E-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Hanna Y. Palhuyeva.
